aml: data to look forward to in 2018 and beyond
Published 6 years ago • 142 plays • Length 2:01Download video MP4
Download video MP3
Similar videos
-
0:52
aml immunotherapy: pre-clinical data to look forward to at ash 2017
-
1:28
the role of allogeneic transplantation in patients with aml in the frontline setting
-
0:35
tct 2021: what to look forward to
-
2:09
advances in the management of fit adults with aml
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:02
the impact of sequencing in aml
-
3:16
what to look forward to at imw 2021
-
2:26
optical genome mapping as a perfect technique for interrogating structural variants
-
58:48
optical mapping in rare genetic disease diagnosis
-
7:46
updates in aml treatment and research from asco 2023
-
1:03
personalizing aml treatment by targeting mrd mutations
-
2:12
allosct for aml with mds-related features as per the icc and who 2022 classifications
-
2:43
diagnostic tools for aml
-
0:53
go-flag: bridge therapy to allo-sct in r/r aml
-
0:57
potential approval of quizartinib in aml & its place in the aml treatment regimen
-
1:40
updates on the use of molecular monitoring to detect mrd in aml
-
1:00
isct 2020: looking forward to advances and emerging technologies in immune-mediated cancer therapy
-
1:34
current research in aml
-
0:46
comy 2020 - what can we look forward to?
-
11:42
aml treatment: what does the data say?
-
1:04
optical genome mapping to detect abnormalities in aml